Literature DB >> 6583694

Evaluation of critical groups required for the binding of heparin to antithrombin.

D H Atha, A W Stephens, R D Rosenberg.   

Abstract

We have examined the quantitative importance of various monosaccharide residues of an octasaccharide domain of heparin that are responsible for the binding of this oligosaccharide to antithrombin. Different fragments of the octasaccharide were prepared by enzymatic digestion and the avidities of these oligosaccharides for antithrombin were determined by equilibrium dialysis. The data show that the non-reducing-end and the reducing-end tetrasaccharides contribute equally to the binding energy of the octasaccharide. The O6-sulfate group of the N-acetyl glucosamine moiety within the nonreducing-end tetrasaccharide is responsible for approximately equal to 45% of the binding energy of the octasaccharide. Neither the two non-sulfated uronic acid groups that flank this residue nor the N-sulfated glucosamine residue on the reducing end of this tetrasaccharide sequence that bears the unique O3-sulfate substituent contribute significantly to the binding energy of the octasaccharide. We suggest that the lack of sulfation of the two uronic acid moieties within the nonreducing-end tetrasaccharide may be required to permit the N-acetyl glucosamine O6-sulfate group to interact with a specific region on the antithrombin molecule. However, we cannot exclude the possibility that the O3-sulfate group plays an important role in orienting this O6-sulfate group within the nonreducing-end tetrasaccharide.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6583694      PMCID: PMC344757          DOI: 10.1073/pnas.81.4.1030

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  A modified uronic acid carbazole reaction.

Authors:  T BITTER; H M MUIR
Journal:  Anal Biochem       Date:  1962-10       Impact factor: 3.365

2.  The separation of active and inactive forms of heparin.

Authors:  L H Lam; J E Silbert; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

3.  Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.

Authors:  M Höök; I Björk; J Hopwood; U Lindahl
Journal:  FEBS Lett       Date:  1976-07-01       Impact factor: 4.124

4.  Stoichiometry of the nitrous acid deaminative cleavage of model amino sugar glycosides and glycosaminoglycuronans.

Authors:  J E Shively; H E Conrad
Journal:  Biochemistry       Date:  1970-01-06       Impact factor: 3.162

5.  Studies on heparin degradation. I. Preparation of ( 35 S) sulphamate derivatives for studies on heparin degrading enzymes of mammalian origin.

Authors:  A G Lloyd; G Embery; L J Fowler
Journal:  Biochem Pharmacol       Date:  1971-03       Impact factor: 5.858

Review 6.  Chemistry of the hemostatic mechanism and its relationship to the action of heparin.

Authors:  R D Rosenberg
Journal:  Fed Proc       Date:  1977-01

7.  Antithrombin-heparin cofactor.

Authors:  P S Damus; R D Rosenberg
Journal:  Methods Enzymol       Date:  1976       Impact factor: 1.600

8.  Selective N-desulfation of heparin with dimethyl sulfoxide containing water or methanol.

Authors:  Y Inoue; K Nagasawa
Journal:  Carbohydr Res       Date:  1976-01       Impact factor: 2.104

9.  Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures.

Authors:  J E Shively; H E Conrad
Journal:  Biochemistry       Date:  1976-09-07       Impact factor: 3.162

10.  The size and shape of human and bovine antithrombin III.

Authors:  B Nordenman; C Nyström; I Björk
Journal:  Eur J Biochem       Date:  1977-08-15
View more
  17 in total

1.  Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.

Authors:  Guoyun Li; Bo Yang; Lingyun Li; Fuming Zhang; Changhu Xue; Robert J Linhardt
Journal:  Anal Biochem       Date:  2014-03-28       Impact factor: 3.365

2.  FGF-FGFR signaling mediated through glycosaminoglycans in microtiter plate and cell-based microarray platforms.

Authors:  Eric Sterner; Luciana Meli; Seok-Joon Kwon; Jonathan S Dordick; Robert J Linhardt
Journal:  Biochemistry       Date:  2013-12-06       Impact factor: 3.162

3.  Ex vivo model of an immobilized-enzyme reactor.

Authors:  H Bernstein; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Mapping and quantification of the major oligosaccharide components of heparin.

Authors:  R J Linhardt; K G Rice; Y S Kim; D L Lohse; H M Wang; D Loganathan
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

5.  Spatiotemporal distribution of heparan sulfate epitopes during murine cartilage growth plate development.

Authors:  Ronald R Gomes; Toin H Van Kuppevelt; Mary C Farach-Carson; Daniel D Carson
Journal:  Histochem Cell Biol       Date:  2006-07-12       Impact factor: 4.304

Review 6.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

7.  Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.

Authors:  Sophie M Thompson; David G Fernig; Edwin C Jesudason; Paul D Losty; Els M A van de Westerlo; Toin H van Kuppevelt; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.

Authors:  Joana C Santos; Juliana M F Mesquita; Celso L R Belmiro; Carolina B M da Silveira; Christian Viskov; Pierre A Mourier; Mauro S G Pavão
Journal:  Thromb Res       Date:  2007-05-04       Impact factor: 3.944

9.  Structure of heparin fragments with high affinity for lipoprotein lipase and inhibition of lipoprotein lipase binding to alpha 2-macroglobulin-receptor/low-density-lipoprotein-receptor-related protein by heparin fragments.

Authors:  A Larnkjaer; A Nykjaer; G Olivecrona; H Thøgersen; P B Ostergaard
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

10.  Kinetics of immobilized heparinase in human blood.

Authors:  L E Freed; G V Vunjak-Novakovic; H Bernstein; C L Cooney; R Langer
Journal:  Ann Biomed Eng       Date:  1993       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.